Spinal interleukin-1β in a mouse model of arthritis and joint pain

Arthritis and Rheumatism

Volumn 58, Issue 10, 2008, Pages 3100-3109

  Fiorentino, Paolo M ^a,b   Tallents, Ross H ^a   Miller, Jen Nie H ^a   Brouxhon, Sabine M ^a   O'Banion, M Kerry ^a   Puzas, J Edward ^a   Kyrkanides, Stephanos ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTHRITIS; ARTICLE; BEHAVIOR CHANGE; CISTERNA MAGNA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; ENZYME INHIBITION; FELINE IMMUNODEFICIENCY VIRUS; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORY ANALYSIS; SPINAL CORD DORSAL HORN; TEMPOROMANDIBULAR JOINT; UPREGULATION; ANIMAL; METABOLISM; OSTEOARTHRITIS; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; INTERLEUKIN-1BETA; MICE; MICE, TRANSGENIC; OSTEOARTHRITIS; PAIN; POSTERIOR HORN CELLS; RECEPTORS, INTERLEUKIN-1; TEMPOROMANDIBULAR JOINT; UP-REGULATION;

EID: 54949145332     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23866     Document Type: Article

References (24)

1. Lai YC, Shaftel SS, Miller JH, Tallents RH, Chang Y, Pinkert CA, et al. Intraarticular induction of interleukin-1β expression in the adult mouse, with resultant temporomandibular joint pathologic changes, dysfunction, and pain. Arthritis Rheum 2006;54:1184-97.
2. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al. Interleukin 1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5.
3. Sommer C, Petrausch S, Lindenlaub T, Toyka KV. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999;270:25-8.
4. Souter AJ, Garry MG, Tanelian DL. Spinal interleukin-1β reduces inflammatory pain [published erratum appears in Pain 2000;88:315]. Pain 2000;86:63-8.
5. Schafers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003;23:2517-21.
6. Sweitzer SM, Schubert P, DeLeo JA. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 2001;297:1210-17.
7. Yang L, Blumbergs PC, Jones NR, Manavis J, Sarvestani GT, Ghabriel MN. Early expression and cellular localization of proinflammatory cytokines interleukin-1β, interleukin-6, and tumor necrosis factor-α in human traumatic spinal cord injury. Spine 2004;29:966-71.
8. Choi HS, Ju JS, Lee HJ, Jung CY, Kim BC, Park JS, et al. Effects of TNF-α injected intracisternally on the nociceptive jaw-opening reflex and orofacial formalin test in freely moving rats. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:613-8.
9. XAT mouse model of arthritis by intraarticular induction of μ-opioid receptor into the temporomandibular joint. Arthritis Rheum 2007;56:2038-48.
10. Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, et al. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain [review]. Arthritis Rheum 1994;37:965-82.
11. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007;27:6006-18.
12. Souter AJ, Garry MG, Tanelian DL. Spinal IL-1β reduces inflammatory pain [published erratum appears in Pain 2000;88:315]. Pain 2000;86:63-8.
13. Kim HD, Lee HJ, Choi HS, Ju JS, Jung CY, Bae YC, et al. IL-1β injected intracisternally inhibited NMDA-evoked behavioral response in the orofacial area of freely moving rats. Neurosci Lett 2004;360:37-40.
14. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JH, Johnson RE, O'Banion MK. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 2007;117:1595-604.
15. Sluka KA, Westlund KN. Behavioral and immunohistochemical changes in an experimental arthritis model in rats. Pain 1993;55:367-77.
16. Boyle DL, Jones TL, Hammaker D, Svensson CI, Rosengren S, Albani S, et al. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med 2006;3:e338.
17. Sorkin LS, Moore J, Boyle DL, Yang L, Firestein GS. Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol 2003;184:162-8.
18. Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986;6:3423-9.
19. Appelgren A, Appelgren B, Eriksson S, Kopp S, Lundeberg T, Nylander M, et al. Neuropeptides in temporomandibular joints with rheumatoid arthritis: a clinical study. Scand J Dent Res 1991;99:519-21.
20. Gouze-Decaris E, Philippe L, Minn A, Haouzi P, Gillet P, Netter P, et al. Neurophysiological basis for neurogenic-mediated articular cartilage anabolism alteration. Am J Physiol Regul Integr Comp Physiol 2001;280:R115-22.
21. Salo PT, Seeratten RA, Erwin WM, Bray RC. Evidence for a neuropathic contribution to the development of spontaneous knee osteoarthrosis in a mouse model. Acta Orthop Scand 2002;73:77-84.
22. Niissalo S, Hukkanen M, Imai S, Tornwall J, Konttinen YT. Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci 2002;966:384-99.
23. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995;128:713]. J Cell Biol 1994;127:1755-66.
24. Edoff K, Hildebrand C. Neuropeptide effects on rat chondrocytes and perichondrial cells in vitro. Neuropeptides 2003;37:316-8.